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Abstract
Piecewise (or non-smooth) glucose-insulin models with threshold windows
for type 1 and type 2 diabetes mellitus are proposed and analyzed with a
view to improving understanding of the glucose-insulin regulatory system.
For glucose-insulin models with a single threshold, the existence and stabil-
ity of regular, virtual, pseudo-equilibria and tangent points are addressed.
Then the relations between regular equilibria and a pseudo-equilibrium are
studied. Furthermore, the sucient and necessary conditions for the global
stability of regular equilibria and the pseudo-equilibrium are provided by us-
ing qualitative analysis techniques of non-smooth Filippov dynamic systems.
Sliding bifurcations related to boundary node bifurcations were investigated
with theoretical and numerical techniques, and insulin clinical therapies are
discussed. For glucose-insulin models with a threshold window, the eects
of glucose thresholds or the widths of threshold windows on the durations
of insulin therapy and glucose infusion were addressed. The duration of the
eects of an insulin injection is sensitive to the variation of thresholds. Our
results indicate that blood glucose level can be maintained within a normal
range using piecewise glucose-insulin models with a single threshold or a
threshold window. Moreover, our ndings suggest that it is critical to indi-
vidualize insulin therapy for each patient separately, based on initial blood
glucose levels.
Keywords: Glucose-insulin model, Insulin therapy, Sliding bifurcation,
Duration, Blood glucose level
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1. Introduction
Diabetes mellitus is an epidemic disease worldwide, characterized by
plasma glucose concentrations mostly remaining above the normal range.
Depending on the pathogenic mechanisms involved, diabetes is classied into
two main categories: type 1 and type 2 diabetes. Type 1 diabetes is generally
due to the immune system of the patients destroying  cells in the islets of
Langerhans of the pancreas and thus preventing production and secretion of
insulin. Type 2 diabetes is mainly due to dysfunction of the glucose-insulin
regulatory system [1, 2]. Since the discovery of diabetes, many researchers
have attempted to nd out how the endocrine metabolic system works [3, 4]
and why there are dysfunctions [5] in order to devise eective and ecient
therapies to improve the daily life of diabetic patients.
In insulin therapies, the subcutaneous injection of insulin or its analogues
by using an insulin pump when needed is a typical treatment. This not only
provides a basic treatment for type 1 diabetes [6], but also supplies a viable
alternative for type 2 diabetes although the latter can be controlled, or even
cured, by life-style changes such as dietary adjustment, physical exercise,
stopping smoking and avoiding exposure to second-hand smoke [7, 8, 9]. Due
to technological diculties, the main obstacle in insulin therapies, however, is
diculty in the monitoring of plasma glucose concentrations non-invasively.
Thus, all current therapies are open-loop treatments that are unable to use
the feedback of glucose concentration automatically [10]. When an accurate
non-invasive glucose monitoring technique is developed, the open-loop treat-
ment could be replaced by closed-loop therapy, with an articial pancreas
delivering insulin automatically according to variations in blood glucose lev-
els [10, 11, 12].
An articial pancreas, which is still being developed would function like
a real and healthy pancreas allowing diabetic patients to control their blood
glucose levels within a normal range automatically [13]. With the help of
such an articial pancreas, patients could improve their life-styles without
injecting insulin manually or measuring the glucose infusion rate. However,
there are two major impediments to the development of an articial pancreas
including the need for reliable predictive models and the lack of eective and
ecient control algorithms [12, 13]. To overcome these problems, several
reliable mathematical models of delay dierential equations which can de-
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termine the time and the dose of insulin injections for control algorithms
have been proposed and investigated [14, 15, 16]. Moreover, pulsatile in-
sulin secretion has been employed to mimic impulsive injections for type 1
or type 2 diabetes mellitus treatment regimes [15, 16]. Recently, Huang et
al. devised a new mathematical model with open-loop control considering
impulsive injection of insulin either periodically or by monitoring the plasma
glucose concentration level [13]. The model can be described by8>>>>>>><>>>>>>>:
dG(t)
dt
= Gin   2G(t)  a

c+
mI(t)
n+ I(t)

G(t) + b;
dI(t)
dt
=
1G
2(t)
21 +G
2(t)
  dI(t);
9>>>=>>>; t 6= h;
G(t+) = G(t);
I(t+) = I(t) + ;

t = h;
(1.1)
where G(t) is the glucose concentration at time t, I(t) is the insulin con-
centration at time t, Gin is the estimated average constant rate of glucose
input, 2 indicates the insulin-independent glucose uptake rate, the term
aG(t)(c + mI(t)=(n + I(t))) stands for the insulin-dependent glucose uti-
lization, b represents the hepatic glucose production, 1G
2(t)=(21 + G
2(t))
is insulin secretion stimulated by elevated glucose concentration caused by
complex pathways including chemical-electrical processes, d indicates the in-
sulin degradation rate. In addition, all parameters are positive (for details
see [13]), with initial condition G(0) = G0 > 0; I(0) = I0 > 0.  is the period
of the impulsive injection of insulin,  denotes the dose of insulin in each in-
jection applied as an impulse at discrete times t = h; h 2 Z+ = f1; 2; 3; :::g.
Note that insulin pumps with an open-loop approach have made signi-
cant contributions to insulin clinical therapies. However, open-loop therapy
changes the life-styles of the patients and increases their likelihoods of be-
coming hyperinsulinaemic or hyperglycaemic. For example, a patient has to
inject insulin at a xed time without monitoring the plasma glucose con-
centrations automatically. So the following questions arise: what is an ideal
treatment for diabetes patients and how does it work? From both practical
and theoretical points of view, the most eective insulin therapy for diabetes
patients is to control their blood glucose levels within a desirable range, once
the blood glucose reaches a critical glucose threshold (CGT) instead of peri-
odic injections of insulin. Meanwhile, when the blood glucose level is below
the critical glucose threshold, diabetes patients can take up glucose normally,
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as shown in Fig. 1.
The critical glucose threshold can be dened as the glucose level in the
blood when insulin injections must be taken to prevent the dangerous glucose
level (DGL) from being reached and exceeded, where the DGL is the blood
glucose level that will cause harm to patients. For example, insulin injections
must be taken once the critical concentration of glucose is observed by a glu-
cose monitoring system so that the DGL cannot be exceeded, i.e., sucient
lead time is needed between the time when the critical concentration of glu-
cose is observed and the time when a treatment is applied (obviously, CGT
is less than DGL). Then it is revealed that the most reasonable treatment is
when insulin is injected automatically in a closed-loop technique integrated
with the glucose monitoring system.
A blood glucose level within the normal range is needed for human body
organs to play their roles in maintaining relevant biological activities. Other-
wise, hyperglycaemia induces glucotoxicity, while hypoglycaemia suppresses
normal functioning of the organs [17]. For these reasons, the patients must
initiate insulin therapy once the blood glucose level has climbed above an up-
per threshold (denoted by GTH , GTH  120mg=dl) and suspend it once the
blood glucose level dips below a lower threshold (denoted by GTH , GTH 
60mg=dl), where [GTH ; G
TH ] is called a threshold window of treatment deci-
sion [18]. In this case, we can extend model (1.1) by replacing the impulsive
injection of insulin by lower and upper thresholds, which can be written as
the following two states.
Glucose infusion state8>>><>>>:
dG(t)
dt
= Gin   2G(t)  a

c+
mI(t)
n+ I(t)

G(t) + b;
dI(t)
dt
=
1G
2(t)
21 +G
2(t)
  dI(t);
until G # GTH :
(1.2)
Insulin injection state8>>><>>>:
dG(t)
dt
= b  2G(t)  a

c+
mI(t)
n+ I(t)

G(t);
dI(t)
dt
=
1G
2(t)
21 +G
2(t)
  dI(t) + ;
until G " GTH : (1.3)
Where all parameters are the same as those in model (1.1). For type 1 di-
abetes, all or most -cells are dysfunctional and thus no insulin is secreted.
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Such a case corresponds to 1 = 0 in models (1.2) and (1.3). For type 2
diabetes, the -cells of patients cannot produce enough insulin or so-called
insulin resistance occurs when the system becomes dysfunctional and pre-
vents cells from taking up glucose eciently. Such a case corresponds to
1 > 0 in models (1.2) and (1.3). Note that according to models (1.2) and
(1.3), for a patient, if G(t0) > G
TH , this patient could be in the insulin in-
jection state; if G(t0) < GTH , he/she could be in the glucose infusion state;
if GTH < G(t0) < G
TH , he/she may either be in the insulin injection state
or be in the glucose infusion state, depending on whether the blood glucose
is tending to increase or decrease.
Moreover, when the lower threshold GTH is equal to the upper threshold
GTH (i.e., GTH = G
TH = GC), then this corresponds to a special case for
models (1.2) and (1.3) with a single threshold. In this case the models (1.2)
and (1.3) can be rewritten as a Filippov system, a model which has been
applied widely in many elds of science and engineering. Furthermore, the
theory of Filippov systems is being recognized as not only richer than the
corresponding theory of continuous systems, but also as representing a more
natural framework for the mathematical modelling of real-world phenomena
[18-29].
The paper is arranged as follows. In section 2, the global dynamics of
models (1.2) and (1.3) with a single threshold are studied in detail: the exis-
tence and stability of several types of equilibria are discussed and the relations
between the existence of a regular equilibrium and a pseudo-equilibrium are
also discussed. Meanwhile, by using qualitative analysis techniques of non-
smooth Filippov dynamic systems the sucient and necessary conditions for
the global stability of regular points and a pseudo-equilibrium are provided,
and then sliding bifurcations related to boundary node bifurcations are in-
vestigated by employing theoretical and numerical techniques. Furthermore,
in section 3, using our proposed piecewise dynamic models with a thresh-
old window we will explore the eects of glucose thresholds or the widths of
threshold windows on the durations of insulin therapy and glucose infusion
processes (i.e., the number of switches between the insulin injection state and
the glucose infusion state).
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2. Qualitative analysis and biological implications of models with
a single threshold
2.1. Qualitative behaviour of models (1.2) and (1.3)
If G < GC , then the qualitative behaviour of system (1.2) is determined
by the following subsystem:8>>><>>>:
dG(t)
dt
= (Gin + b)  G(t)  amI(t)G(t)
n+ I(t)
= P1(G; I);
dI(t)
dt
=
1G
2(t)
21 +G
2(t)
  dI(t) = Q1(G; I);
(2.1)
where we denote  = 2 + ac throughout the paper. For 1  0, there exists
an unique positive equilibrium E1(G1; I1) of system (2.1) with G1 > 0 and
I1 > 0. The linearized system of (2.1) at the equilibrium E1(G1; I1) is as
follows: 8>><>>:
dG(t)
dt
= a11G+ a12I;
dI(t)
dt
= a21G+ a22I;
where a11 =   amI1=(n+I1), a12 =  amnG1=(n+I1)2, a21 = 2211G1=(21+
G21)
2, a22 =  d. Let p =  (a11 + a22), q = a11a22   a12a21, p > 0 and q > 0
hold true provided that G1 > 0 and I1 > 0. Denote 1 = p
2   4q, when
1  0, E1 is a stable node, and when 1 < 0, E1 is a stable focus. Choosing
Dulac function B(G; I) = 1, then we have
@BP1
@G
+
@BQ1
@I
=     amI
n+ I
  d < 0:
Therefore, according to the Bendixson theorem, no closed orbit for system
(2.1) exists, which implies that E1 is globally asymptotically stable.
If G > GC , the qualitative behaviour of system (1.3) is guaranteed by the
following subsystem8>>><>>>:
dG(t)
dt
= b  G(t)  amI(t)G(t)
n+ I(t)
;
dI(t)
dt
=
1G
2(t)
21 +G
2(t)
  dI(t) + ;
(2.2)
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Similarly, there exists an unique equilibrium E2(G2; I2) of system (2.2) with
G2 > 0 and I2 > 0, and E2 is globally asymptotically stable.
Lemma 2.1. E1 of system (2.1) and E2 of system (2.2) are both globally
asymptotically stable.
2.2. Existence of sliding segment
Let
FS1(Z) =

(Gin + b)  G(t)  amI(t)G(t)n+I(t) ; 1G
2(t)
21+G
2(t)
  dI(t)
T
:
= (f1(G; I); g1(G; I))
T ;
FS2(Z) =

b  G(t)  amI(t)G(t)
n+I(t)
; 1G
2(t)
21+G
2(t)
  dI(t) + 
T
:
= (f2(G; I); g2(G; I))
T :
then systems (1.2) and (1.3) can be written as the following Filippov system
[30]
_Z(t) =
(
dZ(t)
dt
= FS1(Z); Z 2 S1;
dZ(t)
dt
= FS2(Z); Z 2 S2;
(2.3)
where
S1 = fZ 2 R2+jH(Z) < 0g; S2 = fZ 2 R2+jH(Z) > 0g
with H(Z) = G GC and R2+ = fZ = (G; I)T jG  0; I  0g:
Furthermore, the discontinuity boundary (or manifold)  separating the
two regions S1 and S2 is described as  = fZ 2 R2+jH(Z) = 0g: From now
on, we call Filippov system (2.3) dened in region S1 and S2 as system S1
and S2, respectively.
Let
(Z) = hHZ(Z); FS1(Z)ihHZ(Z); FS2(Z)i;
where hi denotes the standard scalar product. Then the interior of the sliding
mode domain can be dened as [26, 31, 32]
S = fZ 2 j(Z) < 0g:
According to the denition of (Z), we have
(Z) =

(Gin + b)  GC   amIGC
n+ I



b  GC   amIGC
n+ I

;
7
  
solving the inequality (Z) < 0 yields
Ic2
:
=
n(b  GC)
(am+ )GC   b < I <
n(Gin + b  GC)
(am+ )GC  Gin   b
:
= Ic1:
Therefore, the sliding segment of Filippov system (2.3) can be dened as
S = f(G; I)T 2 R2+jG = GC ;maxfIc2; 0g < I < Ic1g:
2.3. Sliding mode dynamics and existence of the equilibria
The following denitions of all types of equilibria of Filippov system (2.3)
are necessary throughout the paper [19, 26, 31, 32].
Denition 2.1. A point Z is called a regular equilibrium of system (2.3)
if FS1(Z
) = 0, H(Z) < 0 or FS2(Z
) = 0, H(Z) > 0. A point Z is
called a virtual equilibrium of system (2.3) if FS1(Z
) = 0, H(Z) > 0 or
FS2(Z
) = 0, H(Z) < 0.
Denition 2.2. A point Z is called a pseudo-equilibrium if it is an equilib-
rium of the sliding mode of system (2.3), i.e. FS1(Z
) + (1  )FS2(Z) = 0
and 0 <  < 1, where
 =
hHZ(Z); FS2(Z)i
hHZ(Z); FS2(Z)  FS1(Z)i
:
Denition 2.3. A point Z is called a boundary equilibrium of system (2.3)
if FS1(Z
) = 0, H(Z) = 0 or FS2(Z
) = 0, H(Z) = 0.
Denition 2.4. A point Z is called a tangent point of system (2.3) if
Z 2 S; FS(Z) 6= 0 and [FS1 H(Z)][FS2 H(Z)] = 0. Moreover, Z is a
visible (invisible) tangent point of FS1 if FS1 H(Z) = 0 and F 2S1 H(Z) >
0(F 2S1 H(Z) < 0).
The dynamics on the sliding mode S can be obtained by using Utkin
0s
equivalent control method [33], i.e. we have
dI
dt
=
1G
2
C
21 +G
2
C
  dI + 
 
Gin + b  GC   amIGCn+I
Gin
!
= (I):
There may be four types of equilibria for Filippov system (2.3): regular
equilibrium (denoted as ER), virtual equilibrium (denoted as EV ), pseudo-
equilibrium (denoted as EP ) and boundary equilibrium (denoted as EB),
8
  
while the tangent point is denoted as ET . From the analysis of section 2.1,
we have the following results.
We can see that G1 > G2 must hold. Let I1 and I2 be an arbitrarily
constant Id, and substitute it into the rst equation of models (2.1) and
(2.2), thus G1 = (Gin + b)(n + Id)=((am + )Id + n) > b(n + Id)=((am +
)Id + n) = G2. Therefore, if 0 < GC < G2, then E1 becomes a virtual
equilibrium denoted by E1V and E2 is a regular equilibrium denoted by E
2
R.
If G2 < GC < G1, then E1 and E2 are both virtual equilibria. If GC > G1,
then E1 is a regular equilibrium denoted by E
1
R and E2 becomes a virtual
equilibrium denoted by E2V .
Now we investigate the pseudo-equilibrium of the system (2.3). Solving
(I) = 0, we get the following equation
dGinI
2 + AI  B = 0;
where A = dnGin + amGC   (1G2CGin=(21 +G2C) + (Gin + b  GC))
and B = n (1G
2
CGin=(
2
1 +G
2
C) + (Gin + b  GC)). Denote  = A2 +
4dGinB, we get a unique positive root denoted by IP = ( A+
p
)=2dGin.
Therefore, there is an unique positive pseudo-equilibrium EP = (GC ; IP )
provided that IP 2 S.
The tangent points of S satisfy G = GC and
Gin   GC   amI(t)GC
n+ I(t)
+ b = 0; b  GC   amI(t)GC
n+ I(t)
= 0:
Then there are two tangent points denoted as E1T = (GC ; Ic1) and E
2
T =
(GC ; Ic2) for subsystem S1 and S2, respectively.
The boundary equilibrium of Filippov system (2.3) satises G = GC ,
equations (2.1) and (2.2), then the boundary equilibrium of system (2.3) is
obtained as follows
E1B =

GC ;
1G
2
C
d(21 +G
2
C)

; or E1B =

GC ;
1G
2
C
d(21 +G
2
C)
+

d

:
Lemma 2.2. The two virtual equilibria E1V and E
2
V , and the pseudo-
equilibrium EP can coexist in Filippov system (2.3). Further, the pseudo-
equilibrium EP is stable in the sliding domain S.
Proof. When IP 2 (Ic2; Ic1), i.e.
Ic2 <
 A+p
2dGin
< Ic1;
9
  
where Ic1 = n(Gin + b   GC)=((am + )GC   Gin   b) and Ic2 = n(b  
GC)=((am+ )GC   b). By direct calculation, we get G2 < GC < G1. This
inequality is equivalent to the conditions for the coexistence of two virtual
equilibria E1V and E
2
V .
In order to prove that EP is stable in the sliding domain, we only need
to prove that the inequality 0(IP ) < 0. By simple calculation we get
0(IP ) =  d  amnGC
Gin(n+ IP )2
< 0;
therefore, EP is stable. The proof is complete.
Now we investigate the global dynamic behaviour of the Filippov system
(2.3).
2.4. Global qualitative analysis of Filippov system (2.3)
Based on the subsection 2.3, E1T is a tangent point of subsystem S1, E
2
T is a
tangent point of subsystem S2. Further, E
1
T is visible provided that GC 6= G1
and GC > G1, E
1
T is invisible provided that GC 6= G1 and GC < G1. E2T is
visible provided that GC 6= G2 and GC < G2; E2T is invisible provided that
GC 6= G2 and G2 < GC . Then we can get the following theorems.
Theorem 2.3. The equilibrium E2 of Filippov system (2.3) is globally
asymptotically stable if and only if 0  GC < G2.
Theorem 2.4. There exists a globally asymptotically stable pseudo-equilibrium
EP in Filippov system (2.3) if and only if G2  GC  G1.
Theorem 2.5. The equilibrium E1 of Filippov system (2.3) is globally
asymptotically stable if and only if GC > G1.
The proofs of Theorems 2.3, 2.4 and 2.5 are provided in Appendix A,
Appendix B and Appendix C, respectively.
Remark. Based on the above analyses, it is known that for the Filippov
system (2.3) there exist globally asymptotically stable equilibria E1 or E2 or
a pseudo-equilibrium EP under certain conditions. From a biological view-
point, it indicates that with dierent values of the threshold the blood glucose
and the insulin concentrations may stabilize at dierent xed levels repre-
sented by E1, E2 and EP . This suggests that the thresholdGC can be selected
as a basis to control the blood glucose concentration at a desired level within
the normal range.
10
  
Note that the main results would play a key role in determining the
threshold conditions, which guarantee that the blood glucose level is main-
tained within a normal range. In the coming section, we will investigate
the bifurcation analysis and biological implications of model (2.3) for type 2
diabetes, both theoretically and numerically.
2.5. Bifurcation analysis and biological implications of Filippov system (2.3)
for type 2 diabetes
In insulin therapies, the use of an insulin pump provides the basic treat-
ment for diabetes [7, 8, 9]. In section 2.4, the dynamical behaviour of Filippov
system (2.3) has been investigated in detail. In this section, we address the
biological implications of our main results by using bifurcation analysis.
The parameter values for models (1.2) and (1.3) (provided in Table 1)
used in our simulations were either determined by previous research [3, 4,
13, 34, 35], or obtained from models for the intravenous glucose tolerance
test (IVGTT) [35-37]. We converted units as appropriate and adjusted the
values to be within reasonable ranges.
Firstly, the bifurcation set of equilibria and sliding mode will be in-
vestigated. We address the richness of the possible equilibria and slid-
ing modes that Filippov system (2.3) can exhibit; we chose parameters b
and GC to build the bifurcation diagram and xed all other parameters as
those in Table 1. Then we can dene lines for parameters b and GC as
follows: L1 = f(GC ; b)jb = GC((am + )I1 + n)=(n + I1)   Ging, L2 =
f(GC ; b)jb = GC((am+ )I2 + n)=(n+ I2)g ; where I1 = 1G2C=d(21 + G2C)
and I2 = 1G
2
C=d(
2
1 +G
2
C) + =d.
The lines L1 and L2 divide GC and b parameter space into three regions,
and the existence or coexistence of regular or virtual equilibria are indicated
in each region. Note that the boundary equilibrium E1B (or E
2
B ) can exist
only on the line L1 (or L2) and the existence of sliding modes are indicated
in the region between L1 and L2. For example, if we x b = 50mg=min, as
GC increases, then E
1
V and E
2
R coexist ! E1B exists ! E1V , E2V and sliding
domain S coexist! E1B exists! E1R and E2V coexist (for details see Fig.2).
It is clear that bifurcations can occur when one of the parameters, such as
GC , varies, which we will address in more detail below.
A boundary node bifurcation for system (2.3) may occur once the equilib-
ria E2R, E
2
T and E
2
B collide together simultaneously when GC passes through
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a critical value [19, 26]. Choosing the parameter GC = 39:18mg=dl, then the
regular equilibrium E2R, the visible tangent point E
2
T and the boundary equi-
librium E2B can collide together at E
2
B, as shown in Fig.3(b), where GC can be
obtained by GC = b(n+I2)=((am+)I2+n), and this boundary equilibrium
E2B is an attractor with an incoming stable sliding orbit. This implies that
the blood glucose and the insulin concentration can stabilize at a xed level
(i.e. E2B). When GC satises 0 < GC < b(n+ I2)=((am+ )I2+ n), then E1
becomes a virtual equilibrium and E2 is a globally stable regular equilibrium.
Furthermore, the regular equilibrium E2R, the invisible tangent point E
1
T and
the visible tangent point E2T can coexist (see Fig.3(a)). In this case, injection
of insulin controls the blood glucose level at a low level (less than 60mg=dl)
leading to hypoglycaemia, which suppresses normal functioning of the body's
organs. In addition, E2R and E
2
T collide at GC = b(n+ I2)=((am+ )I2+ n),
and are substituted by a stable pseudo-equilibrium EP and an invisible tan-
gent point E2T for b(n+I2)=((am+)I2+n) < GC < (Gin+b)(n+I1)=((am+
)I1 + n), as shown in Fig.4(a) with GC = 100mg=dl. This means that the
blood glucose level stabilizes at the pseudo-equilibrium (100mg=dl), which
indicates that the blood glucose level could be successfully maintained at a
desired level within the normal range. Besides, this bifurcation shows how a
stable node becomes a stable pseudo-equilibrium.
Moreover, another boundary node bifurcation for system (2.3) occurs at
GC = 130:32mg=dl (Fig.4), where GC is obtained by GC = (Gin + b)(n +
I1)=((am + )I1 + n). In this case the boundary equilibrium E
1
B is stable
(Fig.4(b)). The virtual equilibrium E1V , the virtual equilibrium E
2
V , the
invisible tangent point E1T and E
2
T and the stable pseudo-equilibrium EP
coexist when b(n+ I2)=((am+ )I2 + n) < GC < (Gin + b)(n+ I1)=((am+
)I1 + n) with GC = 100mg=dl (see Fig.4(a)). Further, they collide at
GC = (Gin + b)(n + I1)=((am + )I1 + n). When GC > (Gin + b)(n +
I1)=((am+ )I1+ n), there is only a stable regular equilibrium E
1
R and part
of the sliding domain S, as shown in Fig.4(c). This implies that the patient
will be free from insulin therapy, and the blood glucose stabilizes at a high
level (large than 120mg=dl) which leads to hyperglycaemia and glucotoxicity.
Therefore, it suggests that the threshold GC should be carefully chosen by
medical workers to maintain the blood glucose level at a desired level. It
is manifest that this bifurcation indicates how a stable pseudo-equilibrium
becomes a stable node.
From the bifurcation analysis, we can choose the threshold level GC ( for
example, GC = 100mg=dl which belongs to the normal range) such that all
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equilibria of each subsystem such as system S1 and system S2 become vir-
tual, and the pseudo-equilibrium lying in the sliding mode domain is globally
stable. This not only can prevent the possibility of hypoglycaemia and hy-
perglycaemia, but also constrains the blood glucose level to stabilize at a
desired level by insulin therapy. These results clarify that the model (2.3)
for type 2 diabetes proposed here can provide reliable predictive outcomes
to model the regulatory system for diabetes. Similar results can be obtained
for type 1 diabetes (not shown here).
3. Investigations of insulin therapy with a threshold window
The insulin therapy with a single threshold indicates that the blood glu-
cose can be controlled at a desired level within the normal range. Now, we
focus on piecewise glucose-insulin systems (1.2) and (1.3) with two threshold
values, or with a threshold window, which are proposed for modelling the
regulatory system for diabetes. In particular, as discussed in the introduc-
tion, insulin therapy with a threshold window allows a patient to continue
the injection of insulin until his/her blood glucose level drops down to the
lower threshold value GTH , then suspend the therapy; the insulin therapy is
only re-started when the blood glucose level goes over the upper threshold
value GTH . It would be interesting to investigate how the threshold window
governs the durations of insulin therapy and glucose infusion and dynamics of
the blood glucose level, in addition to clinical outcomes. We use the proposed
models (1.2) and (1.3) for these purposes. In order to avoid redundancy, we
mainly focused on type 2 diabetes.
For type 2 diabetes, based on models (1.2) and (1.3), we have G1 > G2.
Generally we assume that G1 > GTH and G2 < G
TH . Then according to
relationships among G1, G2, the lower threshold value GTH and the upper
threshold value GTH , we have the following possible cases:
Case 1: G2 < GTH < G
TH < G1,
Case 2: G2 < GTH < G1 < G
TH ,
Case 3: GTH < G2 < G1 < G
TH ,
Case 4: GTH < G2 < G
TH < G1.
For Case 1, we can easily see that both equilibria E1 and E2 are vir-
tual (see Fig.5(b)). It is clear that virtual equilibria can never be actually
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attained. For example, a trajectory starting, say, in S2 never approaches
a stable virtual equilibrium E2 and reverts to the glucose infusion state as
soon as it crosses the lower threshold GTH , while a trajectory starting in S1
never approaches a stable virtual equilibrium E1 and reverts to the insulin
injection state immediately when it crosses the upper threshold GTH . Com-
bining these two observations, we nd that the system may switch between
the glucose infusion state (1.2) and the insulin injection state (1.3) forever.
Fix all parameter values as those listed in Table 1. Simple calculations give
G1 = 130:32mg=dl and G2 = 39:18mg=dl. Choosing GTH = 65mg=dl and
GTH = 115mg=dl within the normal range, Fig.5(a) shows that, for the given
threshold window, the blood glucose level uctuates periodically during the
whole medical process. The durations of insulin injections and glucose infu-
sions are shown in Fig.5(c), which suggests that the durations of each insulin
injection and glucose infusion are stabilized at xed values and the stable
duration of glucose infusion is larger than the duration of insulin injection.
In particular, we can obtain how fast the blood glucose level rebounds to the
upper threshold value GTH for type 1 diabetes (see Appendix D).
In order to further show the eect of a threshold window on the durations
or number of insulin injections and glucose infusions switches for Case 1, we
consider the following dierent settings for threshold windows (as shown in
Fig.6). First, we xed the width of the threshold window such that GTH  
GTH = 30mg=dl, and let the lower threshold value GTH increase from 60
to 90mg=dl, where GTH = 60 + 1:5(n   1) for n = 1; 2; :::; 21 (see Fig.6(a)
and Fig.6(b)). For the same width of threshold window, it is interesting
to note that as GTH increases, the duration of glucose infusion decreases
(Fig. 6(b)) while the duration of insulin injection increases (Fig.6(a)). This
indicates that, for the same width of threshold window, the larger the lower
threshold value GTH , the more the time needed for the blood glucose level to
fall down to the lower threshold and the less the time needed for the blood
glucose level to rebound to the upper threshold. Secondly, we xed the upper
threshold value GTH = 120mg=dl, and let the lower threshold value GTH
vary from 60 to 90mg=dl with GTH = 60+ 1:5(n  1) for n = 1; 2; :::; 21 (see
Fig.6(c) and Fig.6(d)). It follows that, as GTH increases (and consequently
as the threshold window becomes narrower), it takes more time for the blood
glucose level to fall down or rebound, as shown in Fig.6(c). Finally, we
xed the lower threshold value GTH = 60mg=dl, and let the upper threshold
value GTH increase from 75 to 105mg=dl with GTH = 75 + 1:5(n   1) for
n = 1; 2; :::; 21 (see Fig.6(e) and Fig.6(f)). It is seen that, as GTH increases
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(and consequently as the threshold window becomes wider), the duration
of the insulin injection monotonically increases whilst the duration of the
glucose infusion decreases, and it is observed that the blood glucose level
took more and more time to come down.
It follows from Fig.6(a) and Fig.6(e) that, as the upper threshold GTH
increases, the duration of insulin injection monotonically increases. So an
issue is arising whether there is a certain value of the upper threshold value
GTH above which the insulin injection state with a threshold window cannot
maintain the periodical uctuation of the blood glucose level. Thus, could
the normal range of the blood glucose level be maintained by using insulin
therapy? To answer this question, we focus our discussion on Cases 2   4
below.
For Case 2, the equilibrium E1 becomes a regular steady state, which
is globally stable for system (1.2) only. It is interesting to examine for the
whole systems (1.2) and (1.3) how the blood glucose level behaves. It fol-
lows from Fig.7(a) and Fig.7(b) that any trajectory initiating from region
S1 or S2 approaches the regular equilibrium E1 for GTH = 65mg=dl and
GTH = 140mg=dl. It indicates that for a patient with an upper threshold
for stopping injecting insulin, it may result in a constant blood glucose level
without insulin therapy, which is dangerous for diabetes patients. For Case
3, we have that both equilibria E1 and E2 are regular and globally stable for
their own systems. Fig.7(c) and Fig.7(d) show that the blood glucose level
will approach certain levels represented by the equilibria E1 and E2, cor-
responding to a continuous treatment strategy (the insulin injection state)
and free from insulin therapy (the glucose infusion state), under thresholds
GTH = 30mg=dl and G
TH = 140mg=dl (details see Fig.7(c) and Fig.7(d)).
This suggests that the blood glucose level may be maintained at dierent
xed levels depending on the patient's initial blood glucose level. For Case
4, we have the virtual equilibrium E1 and the regular equilibrium E2, which
is globally stable for system (1.3) only. Similarly to Case 2, the blood glu-
cose level approaches a certain value corresponding to the insulin therapy, as
shown in Fig. 7(e) and Fig.7(f).
4. Conclusion
Since the pioneering work on the dynamics of plasma insulin concen-
trations that led to the glucose-insulin regulatory system contributing to
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insulin therapies, a number of research papers have appeared on the topic
[2, 3, 10, 13, 15, 16, 39, 40]. Numerous studies have focused on the glucose-
insulin regulatory system via a mathematical model of delay dierential equa-
tions. Recently, Huang et al. proposed two novel mathematical models with
impulsive injections of insulin or its analogues for type 1 and type 2 diabetes
mellitus [13], and similar impulsive dierential equations have been widely
used in integrated pest management [28, 29, 41, 42]. In their paper, Huang
et al. assumed that the constant glucose infusion rate Gin is described by a
continuous process and insulin is injected once the blood glucose level reaches
a threshold or at a xed time. However, in clinical insulin therapies, the most
satisfactory treatment would be: if the blood glucose level falls below a crit-
ical threshold, then injection of insulin is not applied and the patients can
take up glucose with constant rate Gin; if the blood glucose level increases
and exceeds a critical threshold, then insulin is injected with dose  auto-
matically and the glucose infusions are suspended. This regime is worked as
a closed-loop technique which is integrated with a glucose monitoring sys-
tem. Therefore, in this paper, we proposed piecewise glucose-insulin dynamic
models with threshold windows, which extended the dynamic model (1.1).
Hence the models formulated here can better describe the eect of insulin
therapy on the blood glucose level.
The dynamics of models (1.2) and (1.3) with a single threshold were in-
vestigated. In particular, the sucient and necessary conditions for the glob-
ally stable regular equilibrium and pseudo-equilibrium are provided by us-
ing qualitative analysis techniques of non-smooth Filippov dynamic systems.
Furthermore, sliding bifurcations with respect to boundary node bifurca-
tions have been studied by employing theoretical and numerical techniques.
The results indicate that when choosing the single threshold GC as a control
parameter, the concentrations of glucose and insulin always stabilize at a reg-
ular equilibrium or a pseudo-equilibrium. However, in insulin therapies, to
prevent the risk of hyperglycaemia or hypoglycaemia, it is critical to choose
a desirable threshold level (here GC) such that all equilibria of each system
such as system S1 and system S2 become virtual, and the pseudo-equilibrium
which is lying in the sliding mode domain is globally stable, then the blood
glucose level can be controlled at a prescribed level within the normal range.
In addition, the dynamical behaviour of models (1.2) and (1.3) for type
2 diabetes with a threshold window were investigated numerically (for type
1 diabetes, the results are similar so we omitted them). We have stud-
ied several dierent scenarios based on the relations between the thresholds
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and equilibria using the proposed models (1.2) and (1.3). Our results show
that the blood glucose level can either uctuate around the two prescribed
thresholds or stabilize at an equilibrium for the insulin injection or glucose
infusion state. In particular, for a patient with a xed blood glucose level at
the treatment starting time, it requires insulin injection and glucose infusion
switches in a treatment regime to maintain the blood glucose level within
the normal range for choosing an appropriate threshold window (for example
65  115mg=dl, see Fig.5). In contrast, if the upper threshold value is larger
or the lower threshold value is smaller than the lower value of a normal range
which corresponds to Case 2, 3 and 4 in section 3, the threshold window can-
not maintain the periodical uctuation of the blood glucose level. This indi-
cates that the blood glucose level will approach certain levels represented by
the equilibrium E1 or E2, corresponding to a continuous treatment strategy
(the insulin injection state) or free from insulin therapy (the glucose infusion
state), both of which increase the risk of hyperglycaemia or hypoglycaemia.
Furthermore, insulin therapy is needed for a patient with a relatively high
blood glucose level, while glucose infusion is required to maintain the blood
glucose level above a safe level. This further conrms that it is important
to individualize the treatment strategy for dierent patients with dierent
initial blood glucose levels. Moreover, we have also shown (see Fig.6) that
the eects of the thresholds and the widths of the threshold windows on the
durations of insulin injection states and glucose infusion states are complex.
The duration of the insulin injection state is more sensitive to the variation
of thresholds compared to that of the glucose infusion state, for details see
Fig.6(a) and Fig.6(e).
Note that the insulin degradation rate is assumed to be proportional to
the insulin concentration, but it is more realistic to assume that the insulin
degradation rate obeys Michaelis-Menten kinetics [16]. Moreover, the eect
of physical exercise on the dynamics of glucose and insulin has been inves-
tigated [43], thus it would be interesting to know how this might aect the
dynamics if we included it in our proposed models. Consequently, we plan
to address these topics with the aim of improving optimal strategies for the
treatment of diabetes in the near future, studies that will be reported else-
where.
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Appendix A: The proof of Theorem 2.3
Note that if 0  GC < G2, then E1 becomes a virtual equilibrium for
subsystem S1 and the tangent point E
1
T of S1 is invisible. Furthermore, E2
is a regular equilibrium for subsystem S2 and the tangent point E
2
T of S2 is
visible, which indicates that the pseudo-equilibrium EP does not exist in this
case. Moreover, from Lemma 2.1, E1 and E2 are both globally asymptotically
stable. Besides, E2 is completely to the right of the threshold line G = GC ,
i.e. in the region S2, see Fig.3(a). Now we prove the global stability of E2 of
Filippov system (2.3).
It is easy to see that any solution initiating from the tangent point E2T
does not meet the threshold line G = GC again due to the stability of E2,
which must tend to E2. On the one hand, any trajectory starting from region
S2 which hits the sliding segment S will move to E
2
T along the sliding domain
and then tend to E2. On the other hand, the solution initiating from region
S2 reaches the threshold line G = GC and above the tangent point E
1
T will
enter into the region S1.
Furthermore, any solution initiating from region S1 of Filippov system
(2.3) will reach the threshold line G = GC in a nite time. The solutions
which meet the S will move to E
2
T and then tend to E2. Clearly, any
trajectory which reaches the threshold line G = GC and below the tangent
point E2T will enter into region S2, and consequently tends to E2. Therefore,
all solutions in system (2.3) nally converge to E2.
Now we show that 0  GC < G2 are necessary conditions for the stability
of E2 of Filippov system (2.3). It is obvious that GC < 0 is impossible. If
GC = G2, then this contradicts the denition of the regular equilibrium of
Filippov system (2.3); if GC > G2, then E2 becomes a virtual equilibrium,
and then the pseudo-equilibrium EP follows which is stable with respect to
sliding mode according to Lemma 2.2. These results contradict the global
stability of the equilibrium E2 of Filippov system (2.3). So 0  GC < G2
must hold. This completes the proof.
Appendix B: The proof of Theorem 2.4
Note that if G2  GC  G1, then E1 and E2 both become virtual equi-
libria E1V and E
2
V for Filippov system (2.3), which indicates that there exists
a stable pseudo-equilibrium EP in the sliding domain for Filippov system
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(2.3) from Lemma 2.2. Further, the tangent point E1T of subsystem S1 and
the tangent point E2T of subsystem S2 are both invisible (Fig.4(a)). Now we
prove the global stability of the pseudo-equilibrium EP of Filippov system
(2.3).
First, all trajectories starting from region S1 and S2 which meet the sliding
domain S will tend to the pseudo-equilibrium EP according to Lemma
2.2. Second, all other trajectories will nally reach the sliding domain S
and converge to the pseudo-equilibrium EP . Otherwise, there must be some
solution initiating from region S1 or S2 tending to another equilibrium, a
limit cycle or innity. These results contradict the properties of vector elds
and nonexistence of a limit cycle of region S1 and S2. Therefore, the pseudo-
equilibrium EP of Filippov system (2.3) is globally asymptotically stable.
Now we prove that G2  GC  G1 are necessary conditions for the sta-
bility of the pseudo-equilibrium EP . We rst prove GC  G2. Otherwise,
the condition GC < G2 ensures the stability of the regular equilibrium E2 of
Filippov system (2.3). Next we show that GC  G1 must hold true. Other-
wise, if GC > G1, then E1 becomes a regular equilibrium, and consequently
the pseudo-equilibrium EP does not exist according to Lemma 2.2. This
contradicts the global stability of the pseudo-equilibrium EP . Thus we have
G2  GC  G1 must hold. The proof is complete.
Appendix C: The proof of Theorem 2.5
If GC > G1, then E1 becomes a regular equilibrium and E2 is a virtual
equilibrium. From Lemma 2.2, the pseudo-equilibrium EP does not exist
(Fig.4(c)). Further, part of the sliding domain S is down below the x-axis.
Therefore, to prove the globally asymptotically stable E1 of Filippov sys-
tem (2.3), we only need to show that all solutions initiating from region S2
will meet the threshold line GC and enter into region S1. In fact, it is evident
that all solutions starting from region S2 meet the threshold line GC and then
enter into region S1 according to the properties of vector elds S2. Further-
more, all solutions initiating from region S1 converge to the equilibrium E1.
Then E1 of Filippov system (2.3) is globally asymptotically stable.
Now we show that GC > G1 must hold true. Otherwise, if GC  G1,
then E1 becomes a virtual equilibrium, and consequently the stable pseudo-
equilibrium EP exists or the stable E2 exists. This contradicts the global
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stability of the equilibrium E1. This completes the proof.
Appendix D: The duration of the glucose infusion state
For type 1 diabetes, the duration of the glucose infusion state can be
described as follows:8>><>>:
dG(t)
dt
= Gin   2G(t)  a

c+
mI(t)
n+ I(t)

G(t) + b;
dI(t)
dt
=  dI(t);
untilG # GTH :
(4.1)
We assume that the rst time the blood glucose level drops and reaches
the lower threshold value GTH is at time t1, i.e., we have T (t1) = GTH . Note
that the analytical solution of the second equation of the model (4.1) with
initial values of T (t1) can be obtained by direct integration, i.e.,
I(t) = I(t1)exp( d(t  t1)); t  t1:
Substituting I(t1) into the rst equation of (4.1) for I(t), then integrating
the rst equation of (4.1) yields
G(t) = G(t1)exp[ (t  t1)]( n+I(t)n+I(t1))
ak
d
+ (Gin + b)(n+ I(t))
ak
d
R t
t1
exp[ (t u)]
(n+I(u))
ak
d
du;
suppose the blood glucose level went to the upper threshold GTH at time t2,
i.e., we have Tt2 = G
TH , then we have the following equation
GTH = GTHexp[ (t2   t1)](n+I(t2)n+I(t1))
ak
d
+ (Gin + b)(n+ I(t2))
ak
d
R t2
t1
exp[ (t2 u)]
(n+I(u))
ak
d
du
and solving the above equation with respect to t2 gives the time t2   t1 of
the blood glucose rebounding from the lower threshold GTH to the upper
threshold GTH .
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Table 1: Parameter values of models (1.2) and (1.3) for type 1 and type 2 diabetes.
Parameters Values Units Parameters Values Units
1 1.27  U/min 2 5 10 6 min 1
a 0.02 mg 1 b 85 mg=min
c 40 mg=min d 0.08 min 1
m 500 mg=min n 80 mg
1 350 mg Gin 50 mg=min
 1 U GTH(G
TH) 60-120 mg=dl
Figure Legends
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Figure 1: Dangerous glucose level (DGL)=lowest blood level that will cause harm to
patients. Critical glucose threshold (CGT)= blood glucose level at which insulin should be
injected to prevent an increasing blood glucose concentration from reaching the dangerous
glucose level for patients. The arrows indicate points when the blood glucose levels exceed
the critical glucose threshold and an insulin therapy method would be applied.
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Figure 2: Bifurcation set of Filippov system (2.3) for type 2 diabetes with respect to b
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Figure 3: Boundary node bifurcation of Filippov system (2.3) for type 2 diabetes. (a)
GC = 25mg=dl; (b) GC = 39:18mg=dl.
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Figure 4: Boundary node bifurcation of Filippov system (2.3) for type 2 diabetes. (a)
GC = 100mg=dl; (b) GC = 130:32mg=dl; (c) GC = 150mg=dl.
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Figure 5: A simulation of typical solution of systems (1.2) and (1.3) for type 2 diabetes
with GTH = 65mg=dl and GTH = 115mg=dl for Case 1. (a) Time series of the blood
glucose level; (b) Phase plane plot of glucose and insulin concentrations; (c) Durations of
insulin injection and glucose infusion for each switch.
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Figure 6: The eects of width of threshold window on the durations of insulin injection (or
glucose infusion) and number of insulin injection and glucose infusion switches of systems
(1.2) and (1.3) for type 2 diabetes. (a, b) We xed the width of threshold window, i.e.,
let GTH  GTH be a constant as 30mg=dl, and GTH increases from 60 to 90mg=dl; (c, d)
We xed the upper threshold value GTH as 120mg=dl and let the lower threshold value
GTH vary from 60 to 90mg=dl; (e, f) We xed the lower threshold value GTH as 60mg=dl
and let the upper threshold value GTH increases from 75 to 105mg=dl.
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Figure 7: Numerical simulations of solutions of systems (1.2) and (1.3) for type 2 diabetes
with dierent lower and upper threshold values. For Case 2: (a, b) Time series of the
blood glucose level and phase plane plot of glucose and insulin concentrations with GTH =
65mg=dl and GTH = 140mg=dl; For Case 3: (c, d) Time series of the blood glucose level
and phase plane plot of glucose and insulin concentrations with GTH = 30mg=dl and
GTH = 140mg=dl: (e, f) Time series of the blood glucose level and phase plane plot of
glucose and insulin concentrations with GTH = 30mg=dl and GTH = 100mg=dl.
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1. We develop novel piecewise glucose-insulin models with a threshold 
window for diabetes mellitus. 
2. Bifurcation analysis and clinical outcomes are addressed for the 
proposed models with a single threshold. 
3. The effects of thresholds on the durations of insulin injection and 
glucose infusion are investigated.  
4. The blood concentrations of patients can be maintained within a 
normal range using the proposed models. 
5. The desirable thresholds must be chosen carefully and insulin therapy 
must be individualized for each patient. 
  
